Immune Cell Injection for Advanced Solid Tumors
Treatments studied
Part of Cancer clinical trials.
This trial tests a new treatment where immune cells (called macrophage exosomes) are injected directly into your tumor to help your body fight the cancer. It's designed for advanced cancers that have not responded to standard treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18–65 years old
- Advanced cancer (cannot be surgically removed or has spread) that has failed standard treatment or you cannot tolerate standard treatment
- Your tumor must be reachable for direct injection (either you can feel it, or doctors can see it with ultrasound or CT scan)
- At least one tumor you can measure on imaging scans
- Reasonable overall health status (able to do light activities or self-care)
- Good organ function (blood counts, liver, kidney, heart, and clotting ability within acceptable ranges)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new immune cell therapy for people with advanced solid tumors (lung, liver, colorectal, or breast cancer). It aims to use your own immune cells to fight the cancer, and might help if standard treatments have stopped working.
This trial tests a personalized treatment that uses your own immune cells, specially trained to find and attack your tumor. It is for people with advanced solid tumors that have not responded to standard treatments.
This study tests an investigational cell therapy (GK01) for people with advanced solid tumors that have grown despite standard treatment or have no standard treatment option. It may help shrink tumors or slow their growth.
This trial tests an experimental treatment called GK01, which uses your own immune cells (called tumor-infiltrating lymphocytes) that have been taken from your tumor, multiplied in a lab, and given back to you. It is for people with advanced solid tumors that have not responded to standard treatments, and aims to see if these cells can shrink your cancer.
This Phase 1 trial tests GT101, an injection made from your own tumor-fighting immune cells, for advanced solid cancers that can’t be removed with surgery. It’s mainly aimed at checking safety and early signs of whether the treatment may work.
This study tests a new treatment using your body's own immune cells (called tumor-infiltrating lymphocytes) that are taken from your tumor, grown in a lab, and then put back into you. It's for people with advanced solid tumors who have run out of standard options.
Hear when a new Advanced Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.